Fresenius Kabi is a leading global healthcare company based in Germany, specializing in the production and distribution of intravenously administered generic drugs, clinical nutrition, and medical devices. The company was founded in 1984 as a subsidiary of Fresenius Group, initially focusing on infusion solutions and renal care. Over the years, it has expanded its product portfolio through organic growth and strategic acquisitions.

Today, Fresenius Kabi operates in over 60 countries and employs more than 37,000 people worldwide. Headquartered in Bad Homburg, Germany, Fresenius Kabi's headquarters serve as the central hub for global operations. It houses key departments such as executive management, legal affairs, finance, and research and development, among others.

The primary products offered by Fresenius Kabi include infusion therapies, clinical nutrition solutions, and medical devices. These products are vital in hospital settings, providing intravenous drugs, parenteral nutrition, and medical equipment necessary for patient care. Fresenius Kabi has a strong global presence with numerous subsidiaries, joint ventures, and partnerships.

Notable subsidiaries include Fenwal Holdings Inc., a leading provider of blood collection and transfusion technology, acquired in 2007, and APP Pharmaceuticals, a leading manufacturer of injectable drugs, acquired in 2008. In terms of market position, Fresenius Kabi holds a significant share in the global healthcare market. It consistently ranks among the top companies in the pharmaceutical sector and operates in highly regulated markets worldwide.

With its diverse product portfolio and global reach, Fresenius Kabi competes effectively with other multinational healthcare companies. Fresenius Kabi has achieved several noteworthy milestones throughout its history. In recent years, the company has focused on expanding its market presence through organic growth and strategic acquisitions, further diversifying its product offerings.

These efforts have strengthened its position as a global leader in the healthcare industry. As of the latest available information, Fresenius Kabi continues to operate successfully, serving patients worldwide with its innovative healthcare solutions. The company remains committed to developing new products and therapies to improve patient outcomes and enhance global healthcare